
Taofiq A Solola
Examiner (ID: 14120, Phone: (571)272-0709 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1626, 1625, 1622, 1613 |
| Total Applications | 3196 |
| Issued Applications | 2336 |
| Pending Applications | 272 |
| Abandoned Applications | 640 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16799020
[patent_doc_number] => 10993935
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-04
[patent_title] => Compositions and methods for treatment of lung infections
[patent_app_type] => utility
[patent_app_number] => 16/429153
[patent_app_country] => US
[patent_app_date] => 2019-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 15
[patent_no_of_words] => 12696
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16429153
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/429153 | Compositions and methods for treatment of lung infections | Jun 2, 2019 | Issued |
Array
(
[id] => 16991751
[patent_doc_number] => 20210230171
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => SELECTIVE A2A RECEPTOR ANTAGONIST
[patent_app_type] => utility
[patent_app_number] => 15/734986
[patent_app_country] => US
[patent_app_date] => 2019-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5947
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15734986
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/734986 | Selective A2A receptor antagonist | Jun 2, 2019 | Issued |
Array
(
[id] => 15209537
[patent_doc_number] => 20190367455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => PROCESS FOR PREPARING 2-(1-(tert-BUTOXYCARBONYL)PIPERIDINE-4-YL)BENZOIC ACID
[patent_app_type] => utility
[patent_app_number] => 16/425166
[patent_app_country] => US
[patent_app_date] => 2019-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5102
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16425166
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/425166 | Process for preparing 2-(1-(tert-butoxycarbonyl)piperidine-4-yl)benzoic acid | May 28, 2019 | Issued |
Array
(
[id] => 17938344
[patent_doc_number] => 11472785
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-18
[patent_title] => Process for purification of tetrahydrocannabinolic- and cannabidiolic acid from plant material extract
[patent_app_type] => utility
[patent_app_number] => 17/261531
[patent_app_country] => US
[patent_app_date] => 2019-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4539
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 203
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17261531
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/261531 | Process for purification of tetrahydrocannabinolic- and cannabidiolic acid from plant material extract | May 21, 2019 | Issued |
Array
(
[id] => 16948070
[patent_doc_number] => 20210206761
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => A PROCESS FOR MAKING PALBOCICLIB
[patent_app_type] => utility
[patent_app_number] => 17/057425
[patent_app_country] => US
[patent_app_date] => 2019-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2966
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17057425
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/057425 | Process for making palbociclib | May 20, 2019 | Issued |
Array
(
[id] => 16932320
[patent_doc_number] => 20210198209
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => METHOD FOR PRODUCING HALOGENATED N-ARYLPYRAZOLES
[patent_app_type] => utility
[patent_app_number] => 17/058032
[patent_app_country] => US
[patent_app_date] => 2019-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6088
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17058032
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/058032 | Method for producing halogenated N-arylpyrazoles | May 19, 2019 | Issued |
Array
(
[id] => 15538857
[patent_doc_number] => 10569189
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2020-02-25
[patent_title] => Method for acetylation of cannabinoids
[patent_app_type] => utility
[patent_app_number] => 16/415782
[patent_app_country] => US
[patent_app_date] => 2019-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 4645
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16415782
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/415782 | Method for acetylation of cannabinoids | May 16, 2019 | Issued |
Array
(
[id] => 16288829
[patent_doc_number] => 10765651
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-08
[patent_title] => Co-crystals of substituted glycine and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/412804
[patent_app_country] => US
[patent_app_date] => 2019-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 22614
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16412804
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/412804 | Co-crystals of substituted glycine and uses thereof | May 14, 2019 | Issued |
Array
(
[id] => 15865937
[patent_doc_number] => 20200140372
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => METHOD FOR PREPARING NITRATE ESTER
[patent_app_type] => utility
[patent_app_number] => 16/413322
[patent_app_country] => US
[patent_app_date] => 2019-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3060
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16413322
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/413322 | Method for preparing nitrate ester | May 14, 2019 | Issued |
Array
(
[id] => 18590200
[patent_doc_number] => 11739080
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-29
[patent_title] => Matrix metalloproteinase (MMP) inhibitors and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 17/055459
[patent_app_country] => US
[patent_app_date] => 2019-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 8
[patent_no_of_words] => 39466
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17055459
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/055459 | Matrix metalloproteinase (MMP) inhibitors and methods of use thereof | May 13, 2019 | Issued |
Array
(
[id] => 15355403
[patent_doc_number] => 10526301
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2020-01-07
[patent_title] => Production of purified dialkyl-furan-2,5-dicarboxylate (DAFD) in a retrofitted DMT plant
[patent_app_type] => utility
[patent_app_number] => 16/408547
[patent_app_country] => US
[patent_app_date] => 2019-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 17391
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16408547
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/408547 | Production of purified dialkyl-furan-2,5-dicarboxylate (DAFD) in a retrofitted DMT plant | May 9, 2019 | Issued |
Array
(
[id] => 15114379
[patent_doc_number] => 20190343822
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-14
[patent_title] => TREATMENT FOR GLAUCOMA
[patent_app_type] => utility
[patent_app_number] => 16/408817
[patent_app_country] => US
[patent_app_date] => 2019-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2330
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16408817
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/408817 | TREATMENT FOR GLAUCOMA | May 9, 2019 | Abandoned |
Array
(
[id] => 18384460
[patent_doc_number] => 11655228
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-23
[patent_title] => Process for preparing dioxolane
[patent_app_type] => utility
[patent_app_number] => 17/056741
[patent_app_country] => US
[patent_app_date] => 2019-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4701
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 280
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17056741
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/056741 | Process for preparing dioxolane | May 7, 2019 | Issued |
Array
(
[id] => 18384461
[patent_doc_number] => 11655229
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-23
[patent_title] => Process for preparing dioxolane
[patent_app_type] => utility
[patent_app_number] => 17/056750
[patent_app_country] => US
[patent_app_date] => 2019-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4623
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 271
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17056750
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/056750 | Process for preparing dioxolane | May 7, 2019 | Issued |
Array
(
[id] => 14746667
[patent_doc_number] => 20190256507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => METHODS AND AGENTS FOR TREATING DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/399888
[patent_app_country] => US
[patent_app_date] => 2019-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19505
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16399888
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/399888 | Methods and agents for treating disease | Apr 29, 2019 | Issued |
Array
(
[id] => 20372721
[patent_doc_number] => 12480148
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-25
[patent_title] => Method for preparing (s)-1,2,3,4-tetrahydroisoquinoline-1 carboxylic acid and derivatives thereof
[patent_app_type] => utility
[patent_app_number] => 17/268455
[patent_app_country] => US
[patent_app_date] => 2019-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 4073
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 210
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17268455
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/268455 | Method for preparing (s)-1,2,3,4-tetrahydroisoquinoline-1 carboxylic acid and derivatives thereof | Apr 22, 2019 | Issued |
Array
(
[id] => 15646573
[patent_doc_number] => 20200085816
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-19
[patent_title] => LSD FOR THE TREATMENT OF ALZHEIMER'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/389591
[patent_app_country] => US
[patent_app_date] => 2019-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8668
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16389591
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/389591 | LSD FOR THE TREATMENT OF ALZHEIMER'S DISEASE | Apr 18, 2019 | Abandoned |
Array
(
[id] => 18604662
[patent_doc_number] => 11746112
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-05
[patent_title] => Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms
[patent_app_type] => utility
[patent_app_number] => 17/048206
[patent_app_country] => US
[patent_app_date] => 2019-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 20663
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17048206
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/048206 | Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms | Apr 17, 2019 | Issued |
Array
(
[id] => 17997811
[patent_doc_number] => 11498905
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-15
[patent_title] => Inhibitors of platelet function and methods for use of the same
[patent_app_type] => utility
[patent_app_number] => 17/047422
[patent_app_country] => US
[patent_app_date] => 2019-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 12
[patent_no_of_words] => 9774
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17047422
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/047422 | Inhibitors of platelet function and methods for use of the same | Apr 16, 2019 | Issued |
Array
(
[id] => 15175313
[patent_doc_number] => 20190358248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-28
[patent_title] => Composition and Methods of Use of Small Molecules as Binding Ligands for the Modulation of Proprotein Convertase Subtilisin/Kexin Type 9(PCSK9) Protein Activity
[patent_app_type] => utility
[patent_app_number] => 16/380414
[patent_app_country] => US
[patent_app_date] => 2019-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16533
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16380414
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/380414 | Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activity | Apr 9, 2019 | Issued |